Results 131 to 140 of about 3,797 (192)

Outcomes of Direct-Acting Antivirals Versus Interferon-Based Therapy in Chronic Hepatitis C Infection.

Cureus
Chowdhury R, Rashid W, Singh T, Rehman A, Daterdiwala NF, Mkosi V, Limbu B, Bukhari SA, Ramadhan A, Dabas MM, Shehryar A, Khan R.   +11 more
europepmc   +1 more source

Polymorphic Structure Determination of the Macrocyclic Drug Paritaprevir by MicroED. [PDF]

Adv Biol (Weinh)
Bu G, Danelius E, Wieske LHE, Gonen T.
europepmc   +1 more source

Safety, tolerability, and pharmacokinetics of faldaprevir after single increasing doses in healthy subjects. [PDF]

Front Pharmacol
Yong CL, Sennewald R, Nehmiz G, Quinson AM, Huang F.   +4 more
europepmc   +1 more source

Drug-induced fever: a pharmacovigilance analysis based on the FDA adverse event reporting system. [PDF]

Int J Clin Pharm
Li X, Zhang W, Wen X, Lin D, Luo X.
europepmc   +1 more source

Accelerating antiviral drug discovery: early hazard detection with a dual zebrafish and cell culture screen of a 403 compound library. [PDF]

Arch Toxicol
Truong L, Bieberich AA, Fatig RO, Rajwa B, Simonich MT, Tanguay RL.   +5 more
europepmc   +1 more source

Development of an inhibitory TTC7B selective nanobody that blocks EFR3 recruitment of PI4KA. [PDF]

J Biol Chem
Suresh S, Shaw AL, Akintola DK, Lunke M, Doerr S, Rohilla P, Balla T, Yip CK, Hansen SD, Cobb JA, Burke JE.   +10 more
europepmc   +1 more source

An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease. [PDF]

Microbiol Spectr
Sigurdardóttir S, Silva SF, Tiukova I, Alalam H, King RD, Grøtli M, Eriksson LA, Sunnerhagen P.   +7 more
europepmc   +1 more source

Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes. [PDF]

Sci Rep
Brzdęk M, Zarębska-Michaluk D, Rzymski P, Lorenc B, Janocha-Litwin J, Berak H, Tomasiewicz K, Sitko M, Mazur W, Janczewska E, Dybowska D, Klapaczyński J, Parfieniuk-Kowerda A, Jaroszewicz J, Piekarska A, Flisiak R.   +15 more
europepmc   +1 more source

Long-Term Outcomes of Patients with Liver Cirrhosis After Eradication of Chronic Hepatitis C with Direct-Acting Antiviral Drugs (DAAs). [PDF]

J Hepatocell Carcinoma
Salama M, Darwesh N, Elsabaawy MM, Abdelsameea E, Gomaa A, Sabry A.   +5 more
europepmc   +1 more source

Hepatitis C: current treatments, emerging therapies and tackling health inequities on the path to global elimination. [PDF]

Clin Med (Lond)
Farooq HZ, Foster GR.
europepmc   +1 more source